462 related articles for article (PubMed ID: 31171626)
1. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.
Zhang M; Qi C; Wang Z; Chen H; Zhao X; Zhang X; Zhou Y; Gao C; Bai Y; Jia S; Ji J
J Mol Med (Berl); 2021 Sep; 99(9):1311-1321. PubMed ID: 34057552
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.
Liu H; Li F; Zhu Y; Li T; Huang H; Lin T; Hu Y; Qi X; Yu J; Li G
Oncotarget; 2016 Jul; 7(28):43894-43906. PubMed ID: 27270314
[TBL] [Abstract][Full Text] [Related]
4. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
Wang R; Dang M; Harada K; Han G; Wang F; Pool Pizzi M; Zhao M; Tatlonghari G; Zhang S; Hao D; Lu Y; Zhao S; Badgwell BD; Blum Murphy M; Shanbhag N; Estrella JS; Roy-Chowdhuri S; Abdelhakeem AAF; Wang Y; Peng G; Hanash S; Calin GA; Song X; Chu Y; Zhang J; Li M; Chen K; Lazar AJ; Futreal A; Song S; Ajani JA; Wang L
Nat Med; 2021 Jan; 27(1):141-151. PubMed ID: 33398161
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.
Song S; Xu Y; Huo L; Zhao S; Wang R; Li Y; Scott AW; Pizzi MP; Wang Y; Fan Y; Harada K; Jin J; Ma L; Yao X; Shanbhag ND; Gan Q; Roy-Chowdhuri S; Badgwell BD; Wang Z; Wang L; Ajani JA
J Exp Clin Cancer Res; 2021 Jun; 40(1):207. PubMed ID: 34162421
[TBL] [Abstract][Full Text] [Related]
7. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets.
Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y
J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811
[TBL] [Abstract][Full Text] [Related]
9. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.
Ajani JA; Xu Y; Huo L; Wang R; Li Y; Wang Y; Pizzi MP; Scott A; Harada K; Ma L; Yao X; Jin J; Zhao W; Dong X; Badgwell BD; Shanbhag N; Tatlonghari G; Estrella JS; Roy-Chowdhuri S; Kobayashi M; Vykoukal JV; Hanash SM; Calin GA; Peng G; Lee JS; Johnson RL; Wang Z; Wang L; Song S
Gut; 2021 Jan; 70(1):55-66. PubMed ID: 32345613
[TBL] [Abstract][Full Text] [Related]
10. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
12. High-density array comparative genomic hybridization detects novel copy number alterations in gastric adenocarcinoma.
Seabra AD; Araújo TM; Mello Junior FA; Di Felipe Ávila Alcântara D; De Barros AP; De Assumpção PP; Montenegro RC; Guimarães AC; Demachki S; Burbano RM; Khayat AS
Anticancer Res; 2014 Nov; 34(11):6405-15. PubMed ID: 25368240
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
[TBL] [Abstract][Full Text] [Related]
14. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Miller ET; You S; Cadaneanu RM; Kim M; Yoon J; Liu ST; Li X; Kwan L; Hodge J; Quist MJ; Grasso CS; Lewis MS; Knudsen BS; Freeman MR; Garraway IP
BMC Cancer; 2020 May; 20(1):398. PubMed ID: 32380981
[TBL] [Abstract][Full Text] [Related]
16. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline
Wang SC; Yeu Y; Hammer STG; Xiao S; Zhu M; Hong C; Clemenceau JR; Yoon LY; Nassour I; Shen J; Agarwal D; Reznik SI; Mansour JC; Yopp AC; Zhu H; Hwang TH; Porembka MR
Cancer Res; 2020 Jun; 80(11):2114-2124. PubMed ID: 32269045
[TBL] [Abstract][Full Text] [Related]
17. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.
Wang R; Song S; Qin J; Yoshimura K; Peng F; Chu Y; Li Y; Fan Y; Jin J; Dang M; Dai E; Pei G; Han G; Hao D; Li Y; Chatterjee D; Harada K; Pizzi MP; Scott AW; Tatlonghari G; Yan X; Xu Z; Hu C; Mo S; Shanbhag N; Lu Y; Sewastjanow-Silva M; Fouad Abdelhakeem AA; Peng G; Hanash SM; Calin GA; Yee C; Mazur P; Marsden AN; Futreal A; Wang Z; Cheng X; Ajani JA; Wang L
Cancer Cell; 2023 Aug; 41(8):1407-1426.e9. PubMed ID: 37419119
[TBL] [Abstract][Full Text] [Related]
18. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
[TBL] [Abstract][Full Text] [Related]
19. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
Liu Z; Wang A; Pu Y; Li Z; Xue R; Zhang C; Xiang X; E JY; Bu Z; Bai F; Ji J
Oncogene; 2021 Sep; 40(38):5705-5717. PubMed ID: 34326469
[TBL] [Abstract][Full Text] [Related]
20. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.
Li Y; Fan Y; Xu J; Huo L; Scott AW; Jin J; Yang B; Shao S; Ma L; Wang Y; Yao X; Pool Pizzi M; Sewastjanow Da Silva M; Zhang G; Zhuo L; Cho EJ; Dalby KN; Shanbhag ND; Wang Z; Li W; Song S; Ajani JA
J Exp Clin Cancer Res; 2022 Aug; 41(1):257. PubMed ID: 35996148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
